Stay updated with breaking news from Cognitive Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the latest findings on its...
Today we can announce the finalists for the NutraIngredients-Asia Awards 2023.
Maintaining mental clarity and having a focused mind is crucial for productive life and overall well-being in today's fast world. While there are various
Diagnosed with lung cancer in the uk is expected to overtake men this year for the first time. and take a look at this, this rather striking image of the london eye, lit up in blue last night as part of celebrations to mark the 75th anniversary of the nhs. buildings lit up. that was yesterday evening. i always think when the london eye is lit up it is a sight to behold. it london eye is lit up it is a sight to behold-— london eye is lit up it is a sight to behold. ., , ., . to behold. it does look magnificent. on the subject _ to behold. it does look magnificent. on the subject of— to beho...
>> lecanemab is the first consistently effective disease modifying therapy for alzheimer's. i think that qualifies it as a game changer. >> reporter: in all thymus patients, amyloid proteins form plaques in the brain which interrupt normal communication between nerve cells, leading to cognitive decline. lecanemab is an antibody that removes existing plaques and prevents new ones from forming. does this new drug actually delay the decline in cognitive function? >> it slows the declined by about 27%. >> reporter: what does that translate into months? >> about six months. >> reporter: the benefit...